Tom Boyles to Tuberculosis, Multidrug-Resistant
This is a "connection" page, showing publications Tom Boyles has written about Tuberculosis, Multidrug-Resistant.
Connection Strength
0,781
-
Why do clinical trials of Xpert® MTB/RIF fail to show an effect on patient relevant outcomes? Int J Tuberc Lung Dis. 2017 03 01; 21(3):249-250.
Score: 0,454
-
Treating drug-resistant tuberculosis in an era of shorter regimens: Insights from rural South Africa. S Afr Med J. 2023 Nov 06; 113(11):47-56.
Score: 0,181
-
A threat to decentralised care for drug-resistant tuberculosis. Lancet Respir Med. 2020 10; 8(10):950-952.
Score: 0,146